Akorn Receives Second Warning Letter In Six Months

 
• By Akriti Seth
  
Warning
Akorn has received an FDA warning letter for its facility in Somerset, New Jersey • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business